Breaking News
October 17, 2018 - FDA Approves Liletta (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Five Years
October 17, 2018 - Weight gain after smoking cessation linked to increased short-term diabetes risk
October 17, 2018 - Researchers find opportunity to control salt-sensitive hypertension without exercising
October 17, 2018 - Modeling Non-Numerical Data in Systems Biology
October 17, 2018 - Research aims to address health disparities in African-American men
October 17, 2018 - Human and cattle decoys trap outdoor-biting mosquitoes in malaria endemic regions
October 17, 2018 - High Circulating Prolactin Level Inversely Linked to T2DM Risk
October 17, 2018 - Study finds gene variant predisposes people to both Type 2 diabetes and low body weight
October 17, 2018 - Metrohm software products make it easy to comply with ALOCA and ALCOA+ guidelines
October 17, 2018 - Network of doctors identify the cause of 31 new conditions
October 17, 2018 - Notable improvement in brain cancer survival among younger patients but not much for elderly
October 17, 2018 - Scientists shed light on roles of transcription factors, TP63 and SOX2, in squamous cell carcinoma
October 17, 2018 - Costs of Medicare Diabetes Prevention Program may be higher than expected reimbursement
October 17, 2018 - Misuse of prescription opioids or benzodiazepines associated with suicidal thoughts
October 17, 2018 - New research seeks to address sex disparities in women’s health
October 17, 2018 - C-Section Rates Have Nearly Doubled Since 2000: Study
October 17, 2018 - Talking to Your Kids About STDs
October 17, 2018 - New classification of periodontal and peri-implant diseases and conditions
October 17, 2018 - Herbert D. Kleber, Pioneer in Addiction Treatment, Dies at 84
October 17, 2018 - Health effects of smoke-filled atmosphere
October 17, 2018 - Down syndrome may hold important clues to onset of Alzheimer’s disease
October 17, 2018 - A special report on US’ aging societies
October 17, 2018 - Birth mode may have acute effects on neurodevelopment, study suggests
October 17, 2018 - Global health innovation system fails to deliver affordable treatments to patients, says report
October 17, 2018 - Simple, inexpensive test quickly detects antibiotic-resistant ‘superbugs’
October 17, 2018 - New drugs could reduce risk of heart disease when added to statins
October 17, 2018 - Visible and valued: Stanford Medicine’s first-ever LGBTQ+ Forum
October 17, 2018 - HVP vaccination not linked with rise in teen risky sex
October 17, 2018 - Potential ‘early warning markers’ for sepsis discovered
October 17, 2018 - Who knew? Life begins (again) at 65
October 17, 2018 - Application of blood pressure guidelines ups treatment
October 17, 2018 - Stanford researchers find that small molecule may help treat enzyme deficiency
October 17, 2018 - Speed Cameras Save Money and Lives in New York City
October 17, 2018 - Men who conform to ‘the man box’ more likely to consider suicide and violence
October 17, 2018 - Researchers aim to create more authentic organoids for drug testing, transplantation
October 16, 2018 - New blood test for pediatric brain tumor patients offers safer approach than surgical biopsies
October 16, 2018 - Age-related estrogen increase may be the culprit behind inguinal hernias in men
October 16, 2018 - Skills-Based Intervention Did Not Cut Systolic BP After Stroke, TIA
October 16, 2018 - Researchers uncover new role of TIP60 protein in controlling tumour formation
October 16, 2018 - Behind the scenes of a lifesaving heart surgery
October 16, 2018 - ‘To See the Suffering’
October 16, 2018 - Drinking concentrated rosemary extract can boost memory by up to 15%, shows research
October 16, 2018 - Medicare Advantage riding high as new insurers flock to sell to seniors
October 16, 2018 - NHS tackles prescription fraud to save millions
October 16, 2018 - New molecular switch may help develop sophisticated photomedications
October 16, 2018 - Improving access to behavioral health screenings for pregnant and postpartum women
October 16, 2018 - Health Highlights: Oct. 12, 2018
October 16, 2018 - Study holds promise for new pediatric brain tumor treatment
October 16, 2018 - Patient advocate uses MRI scans to create art and spark conversations about life with illness
October 16, 2018 - Fish oil based diets may suppress growth and spread of breast cancer cells
October 16, 2018 - Number of VHA facilities offering acupuncture has increased rapidly
October 16, 2018 - Influential Leapfrog Group jumps in to rate 5,600 surgery centers
October 16, 2018 - HIV-infected infants more likely to acquire congenital cytomegalovirus infection
October 16, 2018 - Study pinpoints new marker that can predict Crohn’s disease subtype
October 16, 2018 - Simple procedure could be efficacious intervention for failed back surgery
October 16, 2018 - New research identifies modifiable dementia risk factor in elderly people
October 16, 2018 - Zebrafish study uncovers molecular ‘brake’ that helps control eye lens development
October 16, 2018 - Overlapping copy number variations underlie autism and schizophrenia in Japanese patients
October 16, 2018 - Early menopause and diabetes may reduce life expectancy
October 16, 2018 - Majority of Americans’ ancestry can be traced through existing DNA databases
October 16, 2018 - Patients coerced into mental health care less likely to perceive treatment as effective
October 16, 2018 - Healthy elders can consume walnuts without having negative impact on weight gain, finds study
October 16, 2018 - Interactive robot helps older people exercise and detects underlying health problems
October 16, 2018 - What you need to know about autism spectrum disorder
October 16, 2018 - Antidepressants can be used to treat Alzheimer’s disease
October 16, 2018 - Study uncovers important role of PRMT1 in dilated cardiomyopathy
October 16, 2018 - Nutritional quality of breakfast linked to cardiovascular and metabolic risk factors in children
October 16, 2018 - Study uses novel approach to investigate genetic origins of mental illnesses
October 16, 2018 - Scientists develop dual anthrax-plague vaccine
October 16, 2018 - Poor Outcomes for Hispanic Infants With Congenital Heart Dz
October 16, 2018 - Global study finds youngest in class more likely to be diagnosed with ADHD
October 16, 2018 - Researchers sequence two selfish genes in the fungus Neurospora intermedia
October 16, 2018 - Survey results highlight the need for better communication between patients and HCPs about bacterial vaginosis
October 16, 2018 - Researchers develop fibrin-targeting immunotherapy to protect against neurodegeneration
October 16, 2018 - Researchers create open access database on healthy immunity
October 16, 2018 - Rice University chemist wins big award to study small surfaces
October 16, 2018 - Study finds 43% drop in stroke rate
October 16, 2018 - Researchers identify basic relationships of cell cycle and cellular senescence in the placenta
October 16, 2018 - UA professor receives NSF grant to develop antifouling materials for medical implants
October 16, 2018 - Obesity Doubles Odds for Colon Cancer in Younger Women
UK and European research collaborations receive vote of confidence by three major cancer charities

UK and European research collaborations receive vote of confidence by three major cancer charities

image_pdfDownload PDFimage_print

UK and European research collaborations in cancer research have received a vote of confidence by three major cancer charities, with an announcement today of approximately £30 million into six international projects.

Cancer Research UK is partnering with two of Europe’s leading cancer research charities, AIRC (Associazione Italiana per la Ricerca sul Cancro) and FC AECC (Asociación Española Contra el Cáncer), to invest in six international collaborations, which are aimed at accelerating progress in translational research.

Scientists in the 5-year funded Accelerator Awards projects will investigate the potential of immunotherapies in treating liver cancer; develop manufacturing methods for CAR-T cell production; track cancer cell evolution; investigate drug resistance in blood cancers; devise a blood test for advanced prostate cancer and find new routes for personalising blood cancer treatment.

As the UK and EU work to form a new relationship after Brexit, the awards are an example of how funding organisations are seeking to continue to collaborate post-Brexit to drive research forward.

Dr Iain Foulkes, executive director of research and innovation at Cancer Research UK, said: “No single organisation or country is going to beat cancer on its own. Research must be prioritised as the UK builds a new relationship with the EU, as much-needed breakthroughs in treatment are dependent on collective action from the international research community.

“Our Accelerator Award funding will lay the groundwork for a Europe and UK research pipeline, boosting our life sciences industry, and ensuring basic biological research translates into new innovative treatments in future.”

Each collaboration is aiming to deepen our understanding of cancer and bring us closer to new treatments, making use of the expertise and diverse technologies of the different partner organisations. UK scientists are leading two of the funded programmes, Italian scientists are leading three, and one by a Spanish researcher.

The scope of these awards brings together world-class researchers who would not have previously been able to work together without this funding available. A number of the grants are also focused on training the next generation of early career scientists and clinicians so that the expertise is developed to carry this research forward.

Federico Caligaris Cappio, AIRC scientific director, said: “Cancer research must innovate relentlessly to understand and deal with the complexity of cancer. This requires more investment, coordinated interdisciplinary research and international collaborations, because cancer doesn’t know borders, and research has to overcome them. The partnership with Cancer Research UK and FC AECC has allowed us to fund collaborative projects that promote the development of international networks and the creation of new research tools that could not be done independently at the national level.”

Isabel Orbe, general director of the FC AECC, said: “A global collaboration is needed to accelerate results in cancer research. This charity partnership will provide tools to support researchers in an international framework, helping them to create multidisciplinary networks and support the research of new unexplored areas. Moreover, this call looks to improve cancer research in a global manner and with a clear focus on the patients, with the final aim of defeating cancer.”

Accelerator Award projects include:

  • HUNTER: Hepatocellular Carcinoma Expediter Network – Newcastle University will be leading a project of around £5 million to establish a European and UK network of clinicians and scientists specialising in hepatocellular carcinoma (HCC) – the most common primary liver cancer in adults. The aim will be to understand the immune environment in liver cancer and whether immunotherapies might be effective at treating this disease.
  • Innovative CAR Therapy Platform (INCAR) – The University of Milan-Bicocca will be leading a project of around £4.5 million to support research into CAR T-cell therapy, which is where immune cells are ‘edited’ so that they are more able to target and destroy tumour cells. The team aim to make these therapies more accessible and affordable through developing manufacturing methods and providing recommendations for CAR T-cell immunotherapy development, which could be applied to a broad range of cancer types.
  • Single cell cancer evolution in the clinic – Researchers at Fondazione Centro San Raffaele, Functional Genomics of Cancer Unit, will lead on project with around £4.8 million funding to track cancer cell evolution in organoids, clusters of cells that behave similarly to cells in human organs. Their findings will be used to learn more about drug resistance, and to predict optimal treatment options for relapsed cancer patients.
  • Early detection and intervention: Understanding the mechanisms of transformation and hidden resistance of incurable haematological malignancies – The Clinica Universidad de Navarra is leading on a project of around £4.8 million to investigate blood cancers. The team will seek to uncover the mechanisms of initial tumour resistance to drugs and identify new treatment opportunities for the disease.
  • Multi-modal clinical testing of prostate cancer patients plasma – The University of Trento, Centre for Integrative Biology (CIBIO), are leading on a project worth around £5 million to develop a blood test for advanced prostate cancer treatment selection. The team’s work will look to develop a test ready for clinical studies that will stratify patients into personalised treatment arms.
  • ACRCelerate: Colorectal Cancer Stratified Medicine Network – The Cancer Research UK Beatson Institute in Glasgow will lead on a project with up to £5 million funding to find new routes for personalised bowel cancer treatment. The team will be looking to identify new targets so that patients can be stratified into different treatment groups, which may lower the risks for patients in clinical trials. These methods will also help to reduce the level of animal research required.

Source:

http://www.cancerresearchuk.org/

Tagged with:

About author

Related Articles